Bernal, Hazel Mae .
HRN: 21-90-43 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/01/2023
CEFUROXIME 750MG (VIAL)
05/01/2023
05/07/2023
IV
750mg
Q8hr
Jellyfish Sting Infection
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes